参考文献/References:
[1] SIEGEL R L,MILLER K D,JEMAL A.Cancer statistics[J].CA Cancer J Clin,2020,70(1):7-30.
[2] 薛玉娟,陆爱东,吴珺,等.酪氨酸激酶抑制剂联合化疗治疗儿童Ph阳性急性淋巴细胞白血病的分子学疗效与预后[J].中华实用儿科临床杂志,2020,35(3):201-205.
[3] 张彦平,刘蒙蒙,展新荣.地西他滨联合小剂量高三尖杉酯碱和阿糖胞苷治疗老年急性髓系白血病疗效观察[J].新乡医学院学报,2020,37(11):1068-1074.
[4] LAI C,DOUCETTE K,NORSWORTHY K.Recent drug approvals for acute myeloid leukemia [J].J Hematol Oncol,2019,12(1):100.
[5] BLUM W G,MIMS A S.Treating acute myeloid leukemia in the modern era:a primer [J].Cancer,2020,126(21):4668-4677.
[6] KANTARJIAN H M,KEATING M J,FREIREICH E J.Toward the potential cure of leukemias in the next decade [J].Cancer,2018,124(22):4301-4313.
[7] 张又嘉,陈宇虹,雷苑.表观遗传调控与青光眼发病机制研究进展[J].眼科新进展,2019,39(5):477-481.
[8] SUN T,WU R,MING L.The role of m6A RNA methylation in cancer[J].Biomed Pharmacother,2019,112:1-12.
[9] ZHU Z M,HUO F C,PEI D S.Function and evolution of RNA N6-methyladenosine modification[J].Int J Biol Sci,2020,16(11):1929-1940.
[10] ZHOU Z,LV J,YU H,et al.Mechanism of RNA modification N6-methyladenosine in human cancer[J].Mol Cancer,2020,19(1):104.
[11] LIANG Z,KIDWELL R L,DENG H,et al.Epigenetic N6-methyladenosine modification of RNA and DNA regulates cancer[J].Cancer Biol Med,2020,17(1):9-19.
[12] WIENER D,SCHWARTZ S.The epitranscriptome beyond m6A [J].Nat Rev Genet,2021,22(2):119-131.
[13] ZHAO W,QI X,LIU L,et al.Epigenetic regulation of m6A modifications in human cancer[J].Mol Ther Nucleic Acids,2020,19:405-412.
[14] JIA G,FU Y,ZHAO X,et al.N6-methyladenosine in nuclear RNA is a major substrate of the obesity-associated FTO [J].Nat Chem Biol,2011,7(12):885-887.
[15] HUANG Y,SU R,SHENG Y,et al.Small-molecule targeting of oncogenic FTO demethylase in acute myeloid leukemia[J].Cancer Cell,2019,35(4):677-691.
[16] LI Z,WENG H,SU R,et al.FTO plays an oncogenic role in acute myeloid leukemia as a N6-methyladenosine RNA demethylase[J].Cancer Cell,2017,31(1):127-141.
[17] SU R,DONG L,LI C,et al.R-2HG exhibits anti-tumor activity by targeting FTO/m6A/MYC/ CEBPA signaling[J].Cell,2018,172(1-2):90-105.
[18] HEO S K,NOH E K,KIM J Y,et al.Rhein augments ATRA-induced differentiation of acute promyelocytic leukemia cells [J].Phytomedicine,2018,49:66-74.
[19] CHEN B,YE F,YU L,et al.Development of cell-active N6-methyladenosine RNA demethylase FTO inhibitor [J].J Am Chem Soc,2012,134(43):17963-17971.
[20] ATRASH S,BANO K,HARRISON B,et al.CAR-T treatment for hematological malignancies [J].J Investig Med,2020,68(5):956-964.
[21] PARK S,CHO B S,KIM H J.New agents in acute myeloid leukemia (AML)[J].Blood Res,2020,55(S1):S14-S18.
[22] BARSAN V,RAMAKRISHNA S,DAVIS K L.Immunotherapy for the treatment of acute lymphoblastic leukemia[J].Curr Oncol Rep,2020,22(2):11.
[23] VAGO L,GOJO I.Immune escape and immunotherapy of acute myeloid leukemia[J].J Clin Invest,2020,130(4):1552-1564.
[24] 肖蓬莉,郭淑利,王双琳,等.三氧化二砷联合雷帕霉素对急性髓系白血病THP-1细胞增殖、凋亡及自噬的影响[J].新乡医学院学报,2020,37(9):818-823.
[25] DESROSIERS R,FRIDERICI K,ROTTMAN F.Identification of methylated nucleosides in messenger RNA from Novikoff hepatoma cells[J].Proc Natl Acad Sci U S A,1974,71(10):3971-3975.
[26] YANKOVA E,ASPRIS D,TZELEPIS K.The N6-methyladenosine RNA modification in acute myeloid leukemia[J].Curr Opin Hematol,2021,28(2):80-85.
[27] HEO S K,YUN H J,PARK W H,et al.Rhein inhibits TNF-alpha-induced human aortic smooth muscle cell proliferation via mitochondrial-dependent apoptosis[J].J Vasc Res,2009,46(4):375-386.
[28] LIN S,FUJII M,HOU D X.Rhein induces apoptosis in HL-60 cells via reactive oxygen species-independent mitochondrial death pathway[J].Arch Biochem Biophys,2003,418(2):99-107.
相似文献/References:
[1]孙玲,潘静夫,赵媛英,等.急非淋白血病完全缓解后巩固治疗的对照研究[J].新乡医学院学报,1995,12(04):341.
[2]赵媛英,贺立山.慢粒合并恶性淋巴瘤1例[J].新乡医学院学报,1996,13(01):025.
[3]孙 毅,王文菊,吴铭辉,等.小儿急性白血病强化疗后并发症的综合防治与护理[J].新乡医学院学报,2000,17(06):474.
[4]马禄重 王淑君 丁现超.老年急性非淋巴细胞性白血病25例分析[J].新乡医学院学报,2000,17(04):290.
[5]潘旅玉.三氧化二砷治疗急性早幼粒细胞白血病的护理[J].新乡医学院学报,2001,18(01):072.
[6]聂常富,冯志博,王建国,等.荧光定量RT—PCR检测急性白血病患者外周血WT1基因的表达[J].新乡医学院学报,2002,19(06):467.
[7]张小毅,韩效林,李晓娟.中西医结合治疗白血病化疗致发热40例[J].新乡医学院学报,2003,20(04):267.
[8]刘迎春,王承云,李树军,等.急性白血病患儿父母应对疾病不确定感的质性研究[J].新乡医学院学报,2021,38(2):137.[doi:10.7683/xxyxyxb.2021.02.008]
LIU Yingchun,WANG Chengyun,LI Shujun,et al.Qualitative study on parents′ coping for illness uncertainty in children with acute leukemia[J].Journal of Xinxiang Medical University,2021,38(3):137.[doi:10.7683/xxyxyxb.2021.02.008]
[9]王会平,郜赵伟,刘 冲,等.腺苷脱氨酶抑制剂红-9-(2-羟基-3-壬烷基)腺嘌呤对白血病细胞凋亡及细胞周期的影响[J].新乡医学院学报,2020,37(10):901.[doi:10.7683/xxyxyxb.2020.10.001]
WANG Huiping,GAO Zhaowei,LIU Chong,et al.Effect of adenosine deaminase inhibitor erythro-9-(2-hydroxy-3-nonyl) adenine on cell apoptosis and cell cycle of leukemia cells[J].Journal of Xinxiang Medical University,2020,37(3):901.[doi:10.7683/xxyxyxb.2020.10.001]
[10]隋铭泽,万科成,陈玉雯,等.髓外白血病的生物标志物及治疗进展[J].新乡医学院学报,2023,40(1):088.[doi:10.7683/xxyxyxb.2023.01.016]
SUI Mingze,WAN Kecheng,CHEN Yuwen,et al.Progresses in biomarkers and treatment of extramedullary leukemia[J].Journal of Xinxiang Medical University,2023,40(3):088.[doi:10.7683/xxyxyxb.2023.01.016]